BridgeBio Pharma Inc (BBIO) Company Profile & Statistics

BridgeBio Pharma Inc
BBIO
(Nasdaq - US)
Open
23.10
-0.62 (-2.61%)
in:usd•As of: Nov 18, 2024 12:42 UTC -5
Open
23.54
High
24.17
Low
22.93

About BridgeBio Pharma Inc

CEO

Neil Kumar

Headquarters

3160 porter dr., suite 250

palo alto, ca 94304, united states

Auditor

Deloitte & Touche LLP

Employees

550

Share Holders

Website

www.bridgebio.com

Industry

biotechnology

Sector

health technology

Company Overview

BridgeBio Pharma Inc. discovers, develops and innovates drugs for genetic diseases. The Company's product platform consists of Mendelian, Oncology and Gene therapy. Its product pipeline includes BBP-265, BBP-831, BBP-631 and BBP-454 which are in clinical stage. BridgeBio Pharma Inc. is based in CA, United States.

BridgeBio Pharma Inc Statistics

Valuation Measures

Market Capitalization ²	4.37B
Enterprise Value	5.68B
Enterprise Value/EBITDA (ttm)	-10.55
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	N/A
Price to Sales (ttm)	20.59
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	78.99%
Operating Margin (ttm)	-243.68%
Profit Margin (ttm)	-4743.01%
Return on Equity (ttm)	N/A
Return on Invested Capital (ttm)	-94.43%
Return on Assets (ttm)	-74.34%

Income Statement

Revenue (ttm)	217.76M
Revenue Per Share (ttm)	1.15
Gross Profit (ttm)	215.37M
EBITDA (ttm)³	-538.07M
Net Income Avi to Common (ttm)	-438.86M
Diluted EPS (ttm)	-2.41

Share Statistics

Beta (5Y Monthly)	1.09
52-Week Change	-21.00%
S&P500 52-Week Change	29.70%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	188.99M
Dividend Yield	0.00%
Float ⁴	142.38M
% Held by Insiders	24.66%
% Held by Institutions	99.85%

Balance Sheet

Total Cash (mrq)	405.73M
Total Cash Per Share (mrq)	2.15
Total Debt (mrq)	1.72B
Total Debt/Equity (mrq)	-141.04%
Current Ratio (mrq)	3.19%
Quick Ratio (mrq)	3.19%
Book Value Per Share (mrq)	-6.45

Cash Flow

Operating Cash Flow Per Share (ytd)	-1.73
Free Cash Flow (ytd)	-326.29M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

BridgeBio Pharma Inc

Trade With A Regulated Broker